Treatment of experimental autoimmune encephalomyelitis with antisense oligonucleotides against the low affinity neurotrophin receptor

Journal of Neuroscience Research

Volumn 59, Issue 6, 2000, Pages 712-721

  Soilu Hänninen, Merja ^a   Epa, Ruwan ^b   Shipham, Kylie ^a   Butzkueven, Helmut ^a   Bucci, Tamara ^a   Barrett, Graham ^b   Bartlett, Perry F ^a   Kilpatrick, Trevor J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antisense oligonucleotides; Experimental autoimmune encephalomyelitis; Gene therapy; Low affinity neurotrophin receptor; p75

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; PHOSPHOROTHIOIC ACID; PROTEIN P75; PROTEOLIPID PROTEIN; RNA; SODIUM CHLORIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATION; FEMALE; GENE THERAPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SPLEEN CELL;

ANIMAL; CELL DIVISION; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; GENE THERAPY; MICE; MICE, INBRED STRAINS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, NERVE GROWTH FACTOR; SPLEEN; TREATMENT OUTCOME;

EID: 0034653109     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000315)59:6<712::AID-JNR3>3.0.CO;2-L     Document Type: Article

References (41)

1. The expanding role of nerve growth factor: From neurotrophic activity to immunologic diseases
2. Nerve growth factor receptor expression in fetal, mature, and diseased human kidneys
3. The p75 NGF receptor mediates survival or death of sensory neurons depending on stage of development
4. Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis
5. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75
6. p75 And Trk: A two-receptor system
7. Reducing p75 nerve growth factor receptor levels using antisense oligonucleotides prevents the loss of axotomized sensory neurons in the dorsal root ganglia of newborn rats
8. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor
9. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
10. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones
11. Expression of functional trk protooncogene in human monocytes
12. Oligonucleotides as inhibitors of protein synthesis
13. Microglia-derived nerve growth factor causes cell death in the developing retina
14. Induction of cell death by endogenous nerve growth factor through its p75 receptor
15. Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study
16. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
17. High-affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor
18. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice
19. Expression and structure of the human NGF receptor
20. Nerve growth factor receptor gene expression in human peripheral blood lymphocytes in aging
21. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
22. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues
23. The nerve growth factor family of receptors
24. Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A
25. Low affinity NGF receptor expression in the central nervous system during experimental allergic encephalomyelitis
26. Induction of apoptosis by the low-affinity NGF receptor
27. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor
28. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
29. Nerve growth factor signaling through p75 induces apoptosis in schwann cells via a bcl-2-independent pathway
30. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis
31. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
32. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes
33. Receptors for nerve growth factor on rat spleen mononuclear cells
34. Nerve growth factor is an autocrine survival factor for memory B lymphocytes
35. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice
36. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
37. In vivo modulation of N-myc expression by continuous perfusion with an antisense oligonucleotide
38. Effect of viral infection on experimental allergic encephalomyelitis in mice
39. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
40. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival
41. Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice